SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

Prevention & screening

What Is a Comprehensive Metabolic Panel (CMP) and What Does It Check?

A comprehensive metabolic panel (CMP) is a group of 14 blood tests run from a single draw. It gives your clinician a broad snapshot of kidney function, liver health, blood sugar, and electrolyte balance. A CMP does not diagnose a specific disease by itself—it flags patterns that guide further evaluation.

Talk to a clinician

Nina Osei, NPNurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

What are the 14 tests in a CMP?

A standard CMP measures 14 values across four functional areas 1:

Blood sugar - *Glucose* — the level of sugar circulating in your blood at the time of the draw. Fasting glucose at or above 126 mg/dL on repeat testing meets the American Diabetes Association's diagnostic threshold for diabetes; 100–125 mg/dL suggests prediabetes 2.

Kidney function - *Creatinine* — a waste product of muscle metabolism filtered by the kidneys. When kidneys are not clearing waste efficiently, creatinine rises. - *Blood urea nitrogen (BUN)* — another waste product filtered by the kidneys, though it is also influenced by protein intake, hydration status, and catabolic states. - *Estimated glomerular filtration rate (eGFR)* — not a direct measurement but a calculated estimate derived from creatinine (and sometimes cystatin C), age, and sex. It gives the clearest single number for how well the kidneys are filtering. The 2024 KDIGO guidelines recommend eGFR as the primary marker of kidney filtration and note that the combination of creatinine and cystatin C improves accuracy, though cystatin C is not yet part of the standard CMP 3.

Liver function - *Alanine aminotransferase (ALT)* — a liver-specific enzyme that rises when liver cells are injured or inflamed. - *Aspartate aminotransferase (AST)* — found in liver, heart, muscle, and brain; less liver-specific than ALT. An AST:ALT ratio above 2 raises concern for alcohol-related liver injury 4. - *Alkaline phosphatase (ALP)* — found in the bile ducts, bone, intestine, and placenta. Isolated ALP elevation requires context to identify the source. - *Total bilirubin* — a breakdown product of red blood cells processed by the liver. Elevated levels can cause jaundice and may reflect hemolysis, liver disease, or bile duct obstruction. - *Albumin* — a protein synthesized by the liver; low levels may indicate reduced liver synthetic function, malnutrition, or chronic illness. Albumin also affects how total calcium is interpreted. - *Total protein* — reflects overall protein balance, including albumin and globulins.

Electrolytes and fluid balance - *Sodium* — the principal electrolyte in extracellular fluid; regulates fluid balance, blood pressure, and nerve signaling. - *Potassium* — the principal intracellular cation; essential for heart rhythm, muscle contraction, and nerve function. - *Chloride* — works with sodium to maintain fluid balance and acid-base equilibrium. - *Carbon dioxide (bicarbonate)* — a buffer that reflects the body's acid-base balance; low levels may indicate acidosis, elevated levels may suggest alkalosis.

Calcium is also included. Though often grouped separately, it plays a role in muscle contraction, nerve signaling, bone health, and hormone regulation. Because roughly half of circulating calcium is protein-bound, total calcium results are influenced by albumin levels — a low albumin can make total calcium appear falsely low 1.

Why does a clinician order a CMP?

A CMP is ordered in many clinical settings 1:

  • Routine wellness checkups — as a broad baseline screen alongside a complete blood count (CBC) and lipid panel
  • Monitoring known conditions — diabetes, chronic kidney disease, liver disease, and heart failure all warrant periodic CMP monitoring
  • Before starting or adjusting medications — many common drugs affect CMP values. ACE inhibitors and ARBs predictably raise potassium and may modestly raise creatinine as a hemodynamic effect of lowering intraglomerular pressure — this is generally expected and not a reason to stop the medication, but requires monitoring 5. Statins can occasionally raise ALT and AST. Metformin use in people with kidney disease is typically guided by eGFR thresholds.
  • Evaluating symptoms — fatigue, swelling, nausea, changes in urination, or jaundice may prompt a CMP
  • Before procedures or surgeries — a preoperative baseline

A CMP is rarely ordered in isolation. Paired with a CBC, lipid panel, or hemoglobin A1c (HbA1c), it gives a much broader clinical picture.

How should an abnormal CMP result be interpreted?

A value outside the printed reference range does not automatically mean something is wrong. Standard reference ranges capture the central 95% of a healthy reference population, which means that approximately 1 in 20 healthy people will fall outside the range on any given test by chance alone 6. When 14 values are measured at once, the probability that at least one is flagged in a healthy person rises meaningfully.

Context shapes interpretation far more than the number alone:

  • Creatinine and eGFR must be read against muscle mass, hydration, and recent exercise. A mildly elevated creatinine after intense physical activity is different from a persistently rising creatinine in someone with long-standing diabetes and hypertension. The KDIGO 2024 guidelines emphasize that a single abnormal eGFR does not confirm chronic kidney disease — the finding must persist for at least three months and be considered alongside urine albumin 3.
  • Liver enzymes (ALT, AST, ALP) may be transiently elevated by intense exercise, alcohol, supplements, or certain medications. Clinicians look at the pattern — which enzymes are elevated, by how much, and in what ratio — to distinguish hepatocellular injury from cholestatic processes 4.
  • Glucose is highly sensitive to fasting status. A single non-fasting elevated glucose is not diagnostic; confirmatory testing is required 2.
  • Electrolytes can shift with vomiting, diarrhea, diuretics, dehydration, or kidney disease. A mildly low potassium after a bout of vomiting reads differently than a persistently elevated potassium in someone taking multiple kidney-protective medications.
  • Albumin falls in inflammation and acute illness independent of liver or nutritional status. This is called "negative acute phase reactant" behavior, and a low albumin during a hospitalization may reflect the illness itself rather than a chronic deficit.

Your clinician will interpret your CMP alongside your symptoms, medications, personal history, and trends over time — not as isolated numbers.

How do you prepare for a CMP?

Fasting is recommended when the CMP is drawn for metabolic screening or diabetes evaluation. Fasting means no food or caloric beverages for 8 to 12 hours before the draw; water is encouraged 1. The glucose result is most sensitive to recent eating — a post-meal glucose will not be interpretable against fasting reference ranges or diabetes diagnostic criteria.

In practice: - If your clinician specifically ordered a fasting CMP, follow their instructions. If you are unsure, call the lab or clinic before your appointment. - Drink water before the draw. Dehydration can concentrate values and make a blood draw harder. - Do not stop any medication without speaking to your clinician first — some medications alter CMP values, but discontinuing them may be more harmful than the effect on the result. - Tell the lab technician about recent intense exercise (which can raise creatinine and AST), recent illness, significant alcohol use in the prior 24–48 hours, or any supplements including herbal products. - In hospital or emergency settings, a CMP is often drawn regardless of fasting status because clinical urgency takes precedence.

What follow-up tests might come next?

A CMP is a starting point. Depending on which values are abnormal and by how much, follow-up may include:

| Finding | Common next step | |---|---| | Elevated glucose | Hemoglobin A1c to assess average blood sugar over 2–3 months; repeat fasting glucose to confirm 2 | | Reduced eGFR or rising creatinine | Urine albumin-to-creatinine ratio; repeat labs after 3+ months; consideration of cystatin C for accuracy 3 | | Elevated ALT/AST | Repeat testing; hepatitis B/C serologies; GGT; imaging if elevation persists 4 | | Elevated ALP | GGT or 5'-nucleotidase to distinguish hepatobiliary from bone origin 4 | | Low albumin | Nutritional assessment; acute-phase markers; further liver evaluation if persistent | | Electrolyte abnormalities | Repeat testing, urine electrolytes, medication review, or cardiac monitoring depending on the specific abnormality |

A single abnormal CMP value often prompts a repeat draw before any major clinical decision is made.

Common questions

Is a CMP the same as a basic metabolic panel (BMP)?

No. A BMP measures 8 values — glucose, calcium, sodium, potassium, bicarbonate, chloride, BUN, and creatinine. A CMP includes all 8 of those plus 6 liver-related tests: ALT, AST, ALP, total bilirubin, albumin, and total protein. A CMP gives a more complete picture of liver health.

Can I eat before a CMP blood draw?

It depends on why the CMP was ordered. When glucose is being evaluated for diabetes screening or when a lipid panel is drawn at the same time, fasting for 8 to 12 hours is typically required. If your clinician only wants to check kidney or liver markers, they may accept a non-fasting sample. When in doubt, ask your clinician or lab before your appointment.

My results came back with a few values flagged — should I be worried?

Not necessarily. Reference ranges capture the central 95% of healthy people, so mild deviations are common and often not clinically significant on their own. What matters is the degree of abnormality, whether values are trending, your symptoms, your medications, and your personal medical history. Review results with your clinician before drawing any conclusions.

Does a CMP check for diabetes?

A CMP includes a fasting glucose measurement, which can raise suspicion for prediabetes or diabetes. However, a diagnosis of diabetes requires confirmation — typically either a repeat fasting glucose, an oral glucose tolerance test, or a hemoglobin A1c test. A single CMP glucose is not sufficient on its own for diagnosis.

How often should I get a CMP?

There is no universal answer — frequency depends on your age, underlying conditions, and medications. People with diabetes, kidney disease, liver disease, or who take medications that affect these systems may need monitoring every few months. A healthy adult with no chronic conditions may only need it annually at a wellness visit. Your clinician will guide the right interval for you.

Talk to a clinician

Nina Osei, NPNurse Practitioner

checkups, refills & skin. Gale can match you with a licensed clinician for a visit.

Find care →

When to contact a clinician

  • Jaundice (yellowing of the skin or whites of the eyes) — this warrants prompt evaluation
  • Significantly reduced or absent urine output
  • Severe muscle cramps, weakness, or an irregular heartbeat — these can indicate dangerous electrolyte shifts
  • Extreme fatigue, confusion, or difficulty breathing alongside abnormal CMP results
  • A very low or very high glucose reading with symptoms such as sweating, shakiness, or confusion — seek care promptly

This article explains what a comprehensive metabolic panel measures in general educational terms. It is not a guide to interpreting your personal lab results. Always review your specific results with a licensed clinician who knows your full medical history and current medications. Reference ranges vary by laboratory; what is flagged on your report is specific to the lab that processed your sample.

References

  1. 1.National Library of Medicine (2024). Comprehensive Metabolic Panel (CMP): MedlinePlus Medical Test. MedlinePlus / NLM. linkDefinition of the 14 CMP components, indications for ordering, and fasting preparation guidance
  2. 2.American Diabetes Association Professional Practice Committee (2024). Standards of Care in Diabetes — 2024. Diabetes Care. doi:10.2337/dc24-SINTFasting plasma glucose diagnostic thresholds: ≥126 mg/dL for diabetes, 100–125 mg/dL for prediabetes; fasting defined as no caloric intake for ≥8 hours
  3. 3.Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. doi:10.1016/j.kint.2023.10.018eGFR as primary marker of kidney filtration; creatinine plus cystatin C for improved accuracy; CKD diagnosis requires persistent findings over ≥3 months
  4. 4.Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S (2021). Abnormal liver enzymes: A review for clinicians. World Journal of Hepatology. doi:10.4254/wjh.v13.i11.1688Pattern interpretation of ALT, AST, ALP, bilirubin, and albumin; AST:ALT ratio >2 suggests alcoholic liver disease; ALP sourcing from bone, bile ducts, placenta; hepatocellular vs. cholestatic pattern distinctions
  5. 5.Momoniat T, Ilyas D, Bhandari S (2019). ACE inhibitors and ARBs: Managing potassium and renal function. Cleveland Clinic Journal of Medicine. doi:10.3949/ccjm.86a.18024ACE inhibitors and ARBs predictably raise serum potassium and modestly raise creatinine via hemodynamic reduction in intraglomerular pressure; this is an expected effect requiring monitoring rather than medication discontinuation
  6. 6.Lala V, Zubair M, Minter DA (2023). Liver Function Tests. StatPearls [Internet]. StatPearls Publishing. linkReference range context: standard ranges represent the central 95% of a healthy population; albumin as a marker of synthetic function; ALT more liver-specific than AST; ALP elevation sources; pattern-based interpretation approach

6 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.